 SOLANA BEACH, Calif., May 16, 2022 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. Artelo or the Company NASDAQ: ARTL, a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting at the H.C. Wainwright Global Investment Conference which is being held on May 23- May 26, 2022 at the Fontainebleau Miami Beach Hotel, Miami FL. The conference will include virtual and in-person participation. 